|
|
Exchange: |
New York Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
134,770,000 |
Market
Cap: |
18.97(B) |
Last
Volume: |
757,612 |
Avg
Vol: |
1,174,722 |
52
Week Range: |
$120.62 - $144.92 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Laboratories & Research |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
|
S&P 500 |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 724 |
Guru Rank Value : 1.3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Quest Diagnostics provides diagnostic information services. Co. is made up of two businesses: Diagnostic Information Services, which develops and delivers diagnostic information services, providing insights that allow and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (including hospital health systems), health plans, employers, accountable care organizations and direct contract entities; and Diagnostic Solutions, which includes Co.'s risk assessment services business, which provides solutions for insurers, and Co.'s healthcare information technology businesses, which provides solutions for healthcare providers.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
18,097 |
18,097 |
18,097 |
536,229 |
Total Sell Value |
$2,309,019 |
$2,309,019 |
$2,309,019 |
$75,325,755 |
Total People Sold |
4 |
4 |
4 |
7 |
Total Sell Transactions |
7 |
7 |
7 |
25 |
End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Rusckowski Stephen H |
Chairman, President and CEO |
|
2019-02-26 |
4 |
D |
$87.84 |
$586,420 |
D/D |
(6,676) |
197,406 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2019-02-26 |
4 |
D |
$87.84 |
$136,679 |
D/D |
(1,556) |
60,569 |
|
- |
|
Cunningham Everett |
SVP, Commercial |
|
2019-02-25 |
4 |
AS |
$88.23 |
$28,763 |
D/D |
(326) |
40,867 |
|
- |
|
Cunningham Everett |
SVP, Commercial |
|
2019-02-25 |
4 |
D |
$88.24 |
$38,031 |
D/D |
(431) |
41,193 |
|
- |
|
Davis J. E. |
EVP, General Diagnostics |
|
2019-02-25 |
4 |
D |
$88.24 |
$48,267 |
D/D |
(547) |
41,528 |
|
- |
|
Rusckowski Stephen H |
Chairman, President and CEO |
|
2019-02-25 |
4 |
D |
$88.24 |
$204,540 |
D/D |
(2,318) |
204,082 |
|
- |
|
Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
|
2019-02-25 |
4 |
D |
$88.24 |
$32,031 |
D/D |
(363) |
22,793 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2019-02-25 |
4 |
D |
$88.24 |
$32,031 |
D/D |
(363) |
70,590 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2019-02-25 |
4 |
D |
$88.24 |
$58,238 |
D/D |
(660) |
62,125 |
|
- |
|
Klug Robert A |
VP, Corporate Controller |
|
2019-02-25 |
4 |
D |
$88.24 |
$4,588 |
D/D |
(52) |
5,435 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2019-02-25 |
4 |
AS |
$88.23 |
$29,645 |
D/D |
(336) |
41,772 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2019-02-25 |
4 |
D |
$88.24 |
$27,796 |
D/D |
(315) |
42,108 |
|
- |
|
Rusckowski Stephen H |
Chairman, President and CEO |
|
2019-02-22 |
4 |
D |
$88.39 |
$195,784 |
D/D |
(2,215) |
206,400 |
|
- |
|
Davis J. E. |
EVP, General Diagnostics |
|
2019-02-22 |
4 |
D |
$88.39 |
$44,725 |
D/D |
(506) |
42,075 |
|
- |
|
Eglinton Manner Carrie |
SVP, Advanced Diagnostics |
|
2019-02-22 |
4 |
D |
$88.39 |
$34,649 |
D/D |
(392) |
23,156 |
|
- |
|
Doherty Catherine T. |
SVP, Group Exec. Clin. Fran. |
|
2019-02-22 |
4 |
D |
$88.39 |
$29,699 |
D/D |
(336) |
70,953 |
|
- |
|
Guinan Mark |
Executive Vice President & CFO |
|
2019-02-22 |
4 |
D |
$88.39 |
$53,918 |
D/D |
(610) |
62,785 |
|
- |
|
Cunningham Everett |
SVP, Commercial |
|
2019-02-22 |
4 |
D |
$88.39 |
$35,179 |
D/D |
(398) |
41,624 |
|
- |
|
Klug Robert A |
VP, Corporate Controller |
|
2019-02-22 |
4 |
D |
$88.39 |
$4,420 |
D/D |
(50) |
5,487 |
|
- |
|
Wilensky Gail R |
Director |
|
2019-02-22 |
4 |
S |
$87.78 |
$702,216 |
D/D |
(8,000) |
26,604 |
|
- |
|
Wilensky Gail R |
Director |
|
2019-02-22 |
4 |
OE |
$51.55 |
$412,400 |
D/D |
8,000 |
34,604 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2019-02-22 |
4 |
D |
$88.39 |
$25,721 |
D/D |
(291) |
42,423 |
|
- |
|
Cunningham Everett |
SVP, Commercial |
|
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,348 |
42,022 |
|
- |
|
Prevoznik Michael E |
SVP & General Counsel |
|
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
2,886 |
42,714 |
|
- |
|
Rusckowski Stephen H |
Chairman, President and CEO |
|
2019-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
17,546 |
208,615 |
|
- |
|
787 Records found
|
|
Page 17 of 32 |
|
|